QHSLab, Inc.
QHSLab, Inc. Fundamental Analysis
QHSLab, Inc. (USAQ) shows strong financial fundamentals with a PE ratio of -18.12, profit margin of -14.80%, and ROE of 63.03%. The company generates $0.0B in annual revenue with strong year-over-year growth of 51.31%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 69.6/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze USAQ's fundamental strength across five key dimensions:
Efficiency Score
WeakUSAQ struggles to generate sufficient returns from assets.
Valuation Score
ModerateUSAQ shows balanced valuation metrics.
Growth Score
ExcellentUSAQ delivers strong and consistent growth momentum.
Financial Health Score
ModerateUSAQ shows balanced financial health with some risks.
Profitability Score
ModerateUSAQ maintains healthy but balanced margins.
Key Financial Metrics
Is USAQ Expensive or Cheap?
P/E Ratio
USAQ trades at -18.12 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, USAQ's PEG of 3.59 indicates potential overvaluation.
Price to Book
The market values QHSLab, Inc. at -11.47 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 21.41 times EBITDA. This signals the market has high growth expectations.
How Well Does USAQ Make Money?
Net Profit Margin
For every $100 in sales, QHSLab, Inc. keeps $-14.80 as profit after all expenses.
Operating Margin
Core operations generate 6.46 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $63.03 in profit for every $100 of shareholder equity.
ROA
QHSLab, Inc. generates $-22.30 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
QHSLab, Inc. generates limited operating cash flow of $135.13K, signaling weaker underlying cash strength.
Free Cash Flow
QHSLab, Inc. produces free cash flow of $135.13K, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.01 in free cash annually.
FCF Yield
USAQ converts 1.93% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-18.12
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
3.59
vs 25 benchmark
P/B Ratio
Price to book value ratio
-11.47
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.68
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-1.98
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.18
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.63
vs 25 benchmark
ROA
Return on assets percentage
-0.22
vs 25 benchmark
ROCE
Return on capital employed
-0.28
vs 25 benchmark
How USAQ Stacks Against Its Sector Peers
| Metric | USAQ Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -18.12 | 29.45 | Better (Cheaper) |
| ROE | 63.03% | 779.00% | Weak |
| Net Margin | -14.80% | -24930.00% (disorted) | Weak |
| Debt/Equity | -1.98 | 0.26 | Strong (Low Leverage) |
| Current Ratio | 0.18 | 4.65 | Weak Liquidity |
| ROA | -22.30% | -19333.00% (disorted) | Weak |
USAQ outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews QHSLab, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
0.00%
Industry Style: Defensive, Growth, Innovation
DecliningEPS CAGR
18.13%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
155.55%
Industry Style: Defensive, Growth, Innovation
High Growth